BM stromal cells (BMSCs) secrete IL-6, resulting in a STAT3-dependent overexpression of MCL1, a member of the prosurvival BCL2 family, promoting MM survival and resistance to BCL2/BCL-xL inhibitor ABT-737 [39]. Here, MCL1 is linked to Miyoshi myopathy.